HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.

Abstract
K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker. An experimental model of prolongation of the QT interval and torsades de pointes can be induced in rabbits by treatment with clofilium in the presence of the alpha1-adrenoreceptor agonist methoxamine. In this study we examined the effects of K201 with and without methoxamine on the QT and QTc intervals, and determined whether K201 inhibits clofilium-induced torsades de pointes in the presence of methoxamine (15 microg/kg/min) in rabbits (n=74). Administration of K201 (0, 40, 100, 200 and 400 microg/kg/min) with and without methoxamine prolonged the QT interval in a dose-dependent manner, and torsades de pointes did not occur in any animals. However, clofilium (50 microg/kg/min) with methoxamine induced torsades de pointes in all animals (6/6). Torsades de pointes occurred at rates of 100%, 67%, 40% and 0% at K201 concentrations of 0, 50, 200 and 400 microg/kg/min, respectively, in the clofilium-infused torsades de pointes model. Therefore, 400 microg/kg/min of K201 completely inhibited clofilium-induced torsades de pointes and attenuated the increase of repolarization caused by clofilium; the inhibitory effects of K201 may be related to its pharmacological properties as an alpha1-adrenoceptor blocker. Overall, our results show that K201 causes prolongation of the QT and QTc intervals, but does not induce torsades de pointes, with and without alpha1-adrenoceptor stimulation. Furthermore, K201 inhibits clofilium-induced torsades de pointes, despite QT prolongation, suggesting that QT prolongation alone is not a proarrhythmic signal.
AuthorsHisashi Hasumi, Ryuko Matsuda, Ken Shimamoto, Yoshihito Hata, Noboru Kaneko
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 555 Issue 1 Pg. 54-60 (Jan 19 2007) ISSN: 0014-2999 [Print] Netherlands
PMID17112502 (Publication Type: Journal Article)
Chemical References
  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Anti-Arrhythmia Agents
  • Calcium Channel Blockers
  • Cardiotonic Agents
  • Potassium Channel Blockers
  • Quaternary Ammonium Compounds
  • Sodium Channel Blockers
  • Thiazepines
  • K201 compound
  • clofilium
  • Methoxamine
Topics
  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Agonists (pharmacology)
  • Animals
  • Anti-Arrhythmia Agents
  • Blood Pressure (drug effects)
  • Calcium Channel Blockers (pharmacology)
  • Cardiotonic Agents (pharmacology)
  • Electrocardiography
  • Heart Rate (drug effects)
  • Long QT Syndrome (chemically induced, physiopathology)
  • Male
  • Methoxamine (pharmacology)
  • Potassium Channel Blockers (pharmacology)
  • Quaternary Ammonium Compounds
  • Rabbits
  • Sodium Channel Blockers (pharmacology)
  • Thiazepines (pharmacology)
  • Torsades de Pointes (chemically induced, physiopathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: